Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SKW03 is a biological therapeutic developed by Skye Biologics for the non-operative treatment of musculoskeletal conditions, specifically tendinopathies affecting the Achilles, shoulder, elbow, and knee. As part of Skye's second-generation regenerative medicine platform, it utilizes naturally advanced human biological materials to facilitate tissue repair and healing. The product is designed to provide a regenerative alternative to surgical intervention for patients with chronic tendon injuries. While the specific molecular targets and clinical development phase remain undisclosed by the developer, the therapy aims to leverage the innate healing properties of human-derived biologics to restore function in the musculoskeletal system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SKW03.